Organization | Cooperative International Neuromuscular Research Group

Cooperative International Neuromuscular Research Group Report issue

Academic/Hospital Phase 2 Phase 3

Founded: Washington DC United States (2000)

Organization Overview

First Clinical Trial

2000

NCT00016653

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Now

Alternative names

Cooperative International Neuromuscular Research Group | Cooperative International Neuromuscular Research Group (CINRG)

Active Ingredients

Drugs in Phase 3 Trials (5)

creatine (1 trial)

l-glutamine (1 trial)

lisinopril (zestril) (1 trial)

prednisone (meticorten) (3 trials)

ubiquinone (3 trials)

Drugs in Phase 2 Trials (4)

pentoxifylline (trental) (2 trials)

theophylline (synophylate) (1 trial)

vamorolone (Agamree) (4 trials)

viltolarsen (Viltepso) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Muscular Dystrophies (Phase 3)

Muscular Dystrophies, Limb-Girdle (Phase 3)

Muscular Dystrophy, Duchenne (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 14
# of Trial APIs: 9